Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Sell
66,151
-36,988
-36% -$1.19M 0.01% 1059
2026
Q1
$3.42M Buy
103,139
+5,237
+5% +$197K 0.02% 672
2025
Q4
$3.83M Sell
97,902
-2,983
-3% -$124K 0.02% 597
2025
Q3
$4.53M Buy
100,885
+16,436
+19% +$775K 0.03% 457
2025
Q2
$4.15M Buy
84,449
+25,389
+43% +$1.42M 0.03% 414
2025
Q1
$3.25M Buy
59,060
+12,241
+26% +$689K 0.03% 399
2024
Q4
$2.66M Buy
46,819
+13,942
+42% +$794K 0.03% 412
2024
Q3
$1.72M Buy
32,877
+19,393
+144% +$1.01M 0.03% 395
2024
Q2
$730K Buy
+13,484
New +$736K 0.03% 426

Other funds holding CPRT

&Partners's CPRT Position: Q2 2026 in Review

&Partners reduced its Copart (CPRT) stake by 36% in Q2 2026, selling an estimated $1.19M and leaving 66,151 shares worth $1.9M. The position accounts for 0.01% of the portfolio, ranked #1059.

&Partners first reported a position in CPRT in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.53M in Q3 2025. 1,060 funds tracked by Wall St. Rank hold CPRT as of Q2 2026.

  • &Partners held 66,151 shares of Copart worth $1.9M as of Q2 2026.
  • &Partners sold 36,988 Copart shares in Q2 2026, an estimated $1.19M.
  • Copart made up 0.01% of &Partners's portfolio in Q2 2026, its #1059 holding.
  • &Partners first reported a position in Copart in Q2 2024 and has held it in 9 quarters since.
  • &Partners's Copart position peaked at $4.53M in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Copart as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.